CCS


Associated tags: CCS, Health, Diabetes, Medicine, Pharmaceutical industry, Patient, Education, Keck School of Medicine of USC, Conditional sentence, American Diabetes Association, Pediatrics, Children's Hospital Los Angeles, Health insurance, Arti, Humana, University, Medical device, Name, MD

Locations: TEXAS, LOS ANGELES, UNITED STATES, NORTH AMERICA, MS

CCS Launches CX Navigator: Revolutionizing Customer Experience with Cutting-Edge AI

Retrieved on: 
Monday, April 8, 2024

In strengthening its presence within the United States, Call Center Studio is committed to fostering robust relationships and delivering innovative, AI-driven customer experience solutions tailored for the dynamic US market.

Key Points: 
  • Cenk Soyak, CEO of CCS, stated: "We are thrilled to announce CX Navigator, and continue our vision of innovation with a purpose that helps our customers not only drive but revolutionize customer experience.
  • - CX Navigator comprises several modules leveraging the latest LLM and related AI tools: Voicebot and Chatbot creation, modification and continuous enhancement.
  • ● Generative AI Template messaging: our chat product has been enhanced with AI that learns from your customer representatives' conversations!
  • This feature, designed to provide quick responses, effective communication, and improve customer satisfaction, takes the chat experience to the next level.

New Report: People Living with Diabetes Have False Hope in GLP-1s, Strong Demand for More Engagement and Education

Retrieved on: 
Thursday, March 7, 2024

“GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health and well-being of those living with diabetes,” said Dr. Arti Masturzo, Chief Medical Officer at CCS.

Key Points: 
  • “GLP-1 weight loss drugs alone are not a silver bullet when it comes to improving the health and well-being of those living with diabetes,” said Dr. Arti Masturzo, Chief Medical Officer at CCS.
  • Many of these same respondents stressed the value of additional clinical touchpoints to manage their diabetes.
  • At times, infrequent patient engagement and a lack of proper education and coaching can contribute to patients with diabetes facing dangerous and costly health issues.
  • Of that group, 82% also said that the emergency could have been prevented with better support in the management of their diabetes.

Acquisition of Compression Components and Services, LLC Bolsters Operio Group’s Position in the Solid Dose Market

Retrieved on: 
Wednesday, April 5, 2023

Operio Group , an emerging holding company building a global body of brands supplying and supporting the solid dose manufacturing industry, has today announced its acquisition of Compression Components and Services, LLC , a prominent provider of tablet press and capsule filling machines along with numerous services for manufacturers.

Key Points: 
  • Operio Group , an emerging holding company building a global body of brands supplying and supporting the solid dose manufacturing industry, has today announced its acquisition of Compression Components and Services, LLC , a prominent provider of tablet press and capsule filling machines along with numerous services for manufacturers.
  • This acquisition is a part of Operio Group’s ongoing efforts to expand and further strengthen its presence in the solid dose manufacturing industry and will allow CCS the opportunity to enter the U.K., Europe and Asia markets.
  • This integration of companies not only broadens Operio Group’s standing in the solid dose machinery business but also expands the customer reach of CCS to a market outside of the U.S.
    “I am so excited to have the CCS team join Operio Group,” said Alastair Sanderson, CEO of Operio Group.
  • “I am sure that in doing so we can help build CCS to be the market leader globally that it is in the U.S.”

CCS Launches Scientific Advisory Council to Accelerate Advancements in Chronic Care Management

Retrieved on: 
Wednesday, February 1, 2023

This news comes on the heels of the company’s recent announcement that Arti Masturzo, MD, joined CCS as its first-ever Chief Medical Officer.

Key Points: 
  • This news comes on the heels of the company’s recent announcement that Arti Masturzo, MD, joined CCS as its first-ever Chief Medical Officer.
  • Masturzo has assembled a multi-stakeholder group of experts to comprise our newly formed Scientific Advisory Council,” said Tony Vahedian, Chief Executive Officer at CCS.
  • Ding, Ms. Kulkarni, Dr. Wittlin, and Dr. Kaufman each bring unique industry expertise to the council.
  • That’s why CCS chose to assemble its Scientific Advisory Council and take a leadership role in reimagining how providers, health plans, and employers support their patients and members living with costly, debilitating chronic diseases.

CCS Announces New Gestational Diabetes Management Offering as Part of Its Established LivingConnected® Solution

Retrieved on: 
Tuesday, November 8, 2022

DALLAS, Nov. 8, 2022 /PRNewswire/ -- CCS- leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — announces the launch of a Gestational Diabetes Management offering as part of its LivingConnected® solution. This new program is the first of its kind to couple intensive nutrition and clinical coaching with remote monitoring of blood glucose to address the adverse outcomes for mom and baby of uncontrolled gestational diabetes. In addition, Dr. Arti Masturzo has joined CCS in the newly created position of Chief Medical Officer to guide the continued expansion of CCS Health solutions.

Key Points: 
  • DALLAS, Nov. 8, 2022 /PRNewswire/ -- CCS - leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions announces the launch of a Gestational Diabetes Management offering as part of its LivingConnectedsolution.
  • CCS launches a Gestational Diabetes Management program.
  • To learn more about this new Gestational Diabetes Management offering and CCS' LivingConnectedsolution, please visit CCSMed.com .
  • CCS is a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, particularly diabetes.

CCS Announces Innovative Partnership with Welldoc and ZeOmega Aimed at Helping People with Chronic Conditions Lead Healthier Lives while Reducing Healthcare Costs

Retrieved on: 
Thursday, October 13, 2022

DALLAS, Oct. 13, 2022 /PRNewswire/ -- CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — has announced a new technology partnership with Welldoc and ZeOmega to expand its established LivingConnected® solution. This new, proprietary approach to managing chronic conditions will help improve patient outcomes and reduce costs of care for employer groups and health plan customers by integrating clinical device and care utilization data.

Key Points: 
  • At CCS, we know we can do better for these individuals," said Marian Lowe, EVP and GM of Digital Health at CCS.
  • "That's why we're excited to bring together connected device data and marry that to the member's healthcare utilization through this partnership.
  • CCS is a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, particularly diabetes.
  • Welldoc partners with health plans, health systems and employers with the goal of extending care, improving health and reducing costs.

CCS Announces Company Expansion Focused on Accelerating Innovation in Home-Based Diabetes Care Management

Retrieved on: 
Wednesday, August 10, 2022

DALLAS, Aug. 10, 2022 /PRNewswire/ -- CCS, which now includes CCS Medical and CCS Health, has announced an expansion of its business. The company — a leading provider of home-delivered medical supplies for those living with diabetes or other chronic conditions — will be expanding the education, monitoring, and coaching services it offers to create a more collaborative approach to care. This new model incorporates the delivery of products with access to accredited clinicians supported by proprietary data and technology to simplify the patient experience. In addition, CCS has created a new strategic advisory board and added three new advisory board members to help redefine chronic care management at home.

Key Points: 
  • In addition, CCS has created a new strategic advisory board and added three new advisory board members to help redefine chronic care management at home.
  • First, CCS Health couples high-touch, human engagement with technology to assist patients with education and coaching on disease management and product adoption.
  • To learn more about CCS and their integrated approach to redefining home-based chronic care management, visit CCSMed.com .
  • CCS is a leading provider of clinical programs and home-delivered medical supplies for those living with chronic conditions, particularly diabetes.

Palantir Technologies UK named as a Crown Commercial Service supplier

Retrieved on: 
Thursday, April 22, 2021

b'Palantir Technologies (NYSE:PLTR) has been named as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework.\nThis press release features multimedia.

Key Points: 
  • b'Palantir Technologies (NYSE:PLTR) has been named as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework.\nThis press release features multimedia.
  • Additional information is available at https://www.palantir.com .\nCCS supports the public sector to achieve maximum commercial value when procuring common goods and services.
  • In 2019/20, CCS helped the public sector to achieve commercial benefits worth over \xc2\xa31bn - supporting world-class public services that offer best value for taxpayers.
  • These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control.

Cohere Capital Completes Strategic Growth Investment in CCS, a Leading Digital Brand and E-Commerce Retailer

Retrieved on: 
Wednesday, January 20, 2021

Cohere Capital, a Boston-based private equity firm focused on investing in leading tech-enabled middle market companies, announced that it has made a strategic growth investment in Portland, Oregon-based CCS.

Key Points: 
  • Cohere Capital, a Boston-based private equity firm focused on investing in leading tech-enabled middle market companies, announced that it has made a strategic growth investment in Portland, Oregon-based CCS.
  • CCS is a leading direct-to-consumer digital brand and e-commerce retailer of streetwear and skateboard equipment.
  • This investment will allow CCS to continue to invest in new technology-enabled product and service offerings and accelerate its growth and brand momentum.
  • The Cohere team has previously been involved with driving the growth of numerous leading digital marketing and e-commerce companies.